Physician profile
Robert C Hill
NPI 1770521643
$1,613.38
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $745 · 2020: $583 · 2021: $286.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $154.56 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.50 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $128.29 | 2019-2020 | |
| Pfizer INC. | $114.73 | 2019-2020 | |
| Novo Nordisk INC | $112.87 | 2019-2021 | |
| Amarin Pharma, INC. | $106.41 | 2019-2021 | |
| Amgen INC. | $97.81 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $87.64 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $77.71 | 2019-2021 | |
| Boston Scientific Corporation | $74.29 | 2019-2021 | |
| Abbvie INC. | $41.89 | 2020-2021 | |
| Lilly USA, LLC | $40.33 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $40.13 | 2019 | |
| Gilead Sciences, INC. | $39.76 | 2019-2020 | |
| Allergan, INC. | $34.57 | 2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Upsher-Smith Laboratories LLC | $33.80 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $33.55 | 2019-2021 | |
| Sanofi Pasteur INC. | $29.71 | 2019-2020 | |
| Glaxosmithkline, LLC. | $27.85 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $26.10 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $22.77 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $18.42 | 2020 | |
| Nestle Healthcare Nutrition INC. | $16.34 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.74 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.33 | 2020 | |
| Endo Pharmaceuticals INC. | $12.81 | 2020 | |
| Abbott Laboratories | $12.76 | 2019 | |
| Antares Pharma, INC. | $12.06 | 2019 | |
| Jazz Pharmaceuticals INC. | $11.85 | 2021 | |
| Shire North American Group INC | $11.49 | 2019 | |
| Biodelivery Sciences International, INC. | $11.31 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.